Do ADHD Stimulants Really Improve Attention? A New Study Challenges What Psychiatry Thought It Knew

TL;DR

A major 2025 study published in Cell challenges one of the most familiar explanations for how stimulant medications help ADHD. Researchers found that stimulants such as methylphenidate were associated more strongly with brain networks involved in arousal, wakefulness, reward, and motivation than with the brain’s canonical attention networks.

That does not mean stimulant medications do not work. They clearly help many people with ADHD.

Instead, the study raises a more interesting question: Have we misunderstood why they work?

For me, this is also a reminder of something important about psychiatry. Many of the explanations we use are models, not settled truths. Good psychiatric care requires evidence, but it also requires curiosity, humility, and a willingness to update our assumptions as the science changes.

For ADHD in particular, this is one reason I believe treatment should extend beyond medication alone and consider sleep, exercise, nutrition, motivation, environment, stress, work demands, and the structure of a person’s actual life.

What did the new ADHD stimulant study find?

Researchers found that some ADHD medications were associated primarily with changes in brain networks related to arousal and reward rather than the canonical attention networks researchers expected.

The study, published in Cell by Kay and colleagues, analyzed resting-state functional MRI data from 11,875 children ages 8 to 11 participating in the Adolescent Brain Cognitive Development Study. The researchers then validated aspects of their findings in a much smaller precision-imaging experiment involving healthy adults who received methylphenidate.

The findings were surprising.

Stimulant-associated differences appeared prominently in sensorimotor regions associated with arousal and in salience and parietal memory networks involved in reward-motivated behavior.

The researchers did not find comparable effects in canonical attention systems such as the dorsal attention network.

Perhaps even more interestingly, stimulant-associated brain connectivity patterns resembled patterns associated with greater wakefulness and adequate sleep.

The authors propose that stimulants may improve performance partly by making the brain more awake and making a task feel more worth doing.

That is subtly but importantly different from simply saying, “Stimulants improve attention.”

Does this mean ADHD stimulants do not work?

No. This study challenges a proposed mechanism of action, not the clinical effectiveness of stimulant medication.

That distinction is extremely important.

Methylphenidate, amphetamine medications, and other stimulants can produce meaningful improvements for people with ADHD. A patient does not suddenly lose those benefits because scientists develop a better explanation for how the medications produce them.

Instead, this research asks us to reconsider what we mean when someone says a stimulant “helps me focus.”

Perhaps the medication is directly improving an attention system.

But perhaps some of what the person experiences as improved attention results from increased alertness, greater willingness to persist, altered reward processing, or an increased perceived value of completing an otherwise boring task.

In everyday life, those processes are difficult to separate.

If answering 50 emails suddenly feels less painfully tedious, you may complete more emails. Subjectively, you might describe that as better focus.

The neuroscience underneath that improvement may be considerably more complicated.

Is ADHD really an attention disorder?

ADHD involves attention, but describing ADHD simply as an inability to pay attention has always been incomplete.

Many folks with ADHD can concentrate extraordinarily well under the right circumstances.

Give someone with ADHD something novel, urgent, stimulating, competitive, personally meaningful, or intensely interesting and sustained attention may suddenly become much easier.

Then ask that same person to complete expense reports, organize a calendar, answer routine emails, or finish a repetitive administrative task and everything changes.

The brain clearly possesses the capacity for attention.

The problem may involve the regulation and allocation of that attention, along with motivation, reward sensitivity, arousal, executive function, and task initiation.

The Cell study does not settle what ADHD “really is.” But it adds another important piece to a much larger puzzle.

Have we misunderstood how ADHD medications work?

Possibly, probably, actually certainly, at least in part.

For years, explanations of ADHD treatment have often been presented with far more certainty than the underlying neuroscience warrants.

We talk about dopamine. We talk about norepinephrine. We talk about the prefrontal cortex. We sometimes draw neat diagrams suggesting that a medication increases a neurotransmitter, which fixes a particular brain circuit, which improves attention.

The actual brain is considerably messier.

The new study found that stimulant-related functional connectivity changes were strongest in systems associated with arousal, action, salience, reward and memory rather than traditional attention networks.

This does not erase decades of ADHD research. Nor does it establish an entirely new definitive explanation.

It updates the model.

What does this study teach us about psychiatry?

One of the most important lessons is that psychiatric knowledge should remain fluid.

Medicine understandably wants clear answers. Patients want them too. We want to say: this condition happens because of X, and this medication works because of Y.

Sometimes we know those things with considerable confidence.

Sometimes we have a useful working model.

Those are not the same thing.

Psychiatry deals with an organ containing roughly 86 billion neurons interacting through extraordinarily complex electrical, chemical, hormonal, immune, metabolic, and environmental systems. Our ability to observe that system remains limited.

That should not make us nihilistic about psychiatry.

It should make us humble.

The right response to uncertainty is not to reject psychiatric science. It is to practice psychiatry scientifically: form hypotheses, use the best available evidence, observe outcomes, question assumptions, and update the model when better information arrives.

Everything should remain open to refinement.

Why does this support an integrative approach to ADHD?

If ADHD symptoms emerge from interactions among attention, arousal, motivation, reward, executive function and the environment, then treating ADHD should involve more than asking whether a stimulant dose can be increased.

Medication can be enormously helpful. But medication exists inside a biological and behavioral system.

Consider sleep.

The Cell researchers found notable overlap between stimulant-related connectivity patterns and brain patterns associated with sufficient sleep. They also found that stimulant use appeared to reverse some brain and behavioral effects associated with sleep deprivation.

That raises a clinically important question.

If someone continually needs more stimulation to function, should we automatically increase stimulation, or should we also ask why the brain requires so much help staying adequately aroused?

That might mean evaluating sleep duration, sleep consistency, sleep apnea, circadian rhythm, chronic stress, overwork, burnout, physical activity, substance use, medication timing, or other factors.

This is exactly why sleep is something I take seriously when treating ADHD.

Could exercise, nutrition and lifestyle matter more than we think?

Lifestyle interventions are not substitutes for evidence-based ADHD treatment, but they can influence many of the same systems we are trying to optimize.

Exercise can affect arousal, mood, executive functioning, sleep and catecholamine signaling.

Nutrition can influence energy availability, metabolic health and overall brain function.

Sleep affects vigilance, impulse control, working memory and emotional regulation.

Stress changes cognitive performance.

Environment affects how much executive function a person must continuously expend.

Even the structure of someone’s job can dramatically change how impairing ADHD feels.

A highly stimulating entrepreneurial environment may allow one person with ADHD to thrive while a repetitive administrative role leaves the same person feeling almost incapable of functioning.

Context matters.

Should people with ADHD stop taking stimulants?

This study is not evidence that people benefiting from stimulant medication should discontinue treatment.

It is also important not to overinterpret the research.

The large ABCD component involved children ages 8 to 11 taking different stimulant medications, with limitations regarding medication timing and formulation. The controlled methylphenidate validation experiment involved only five highly sampled healthy adults.

The researchers themselves emphasize that “attention” is difficult to define and cannot necessarily be reduced to a single brain network.

So this paper should change the questions we ask, not cause people to abruptly change effective treatment.

What might this mean for finding the right stimulant dose?

The goal of ADHD treatment should be improved functioning, not simply maximizing stimulation.

This is an important distinction in my own approach to ADHD medication management.

More medication is not automatically better medication.

If someone can work for 14 hours without eating, cannot relax in the evening, sleeps poorly, feels emotionally flattened, or requires medication simply to tolerate an unsustainable workload, I would not necessarily consider that optimized ADHD treatment.

Sometimes the answer is adjusting medication.

Sometimes it is adding or considering a non-stimulant strategy.

Sometimes it is improving sleep.

Sometimes it is changing systems and routines.

And occasionally the uncomfortable answer is that medication is being asked to solve a problem that medication cannot actually solve.

No stimulant can make an incompatible career fulfilling, create healthy boundaries, repair chronic sleep deprivation, eliminate an impossible workload, or make every boring task intrinsically interesting.

What does this change about how I approach adult ADHD treatment?

It reinforces my belief that ADHD treatment should begin with curiosity rather than a predetermined answer.

At Proactive Psychiatry in Washington, DC, my approach to ADHD treatment combines evidence-based medication management with a broader evaluation of sleep, exercise, nutrition, stress, executive functioning, physical health, relationships, environment, and daily demands.

Medication may be a major part of that plan.

Sometimes it is transformative.

But the objective is not simply to produce more focus.

I want to understand why a particular person is struggling, what improves their functioning, what makes it worse, and how we can build a sustainable treatment plan around the life they actually want to live.

What should we take away from this study?

Psychiatry should be comfortable saying, “We may need to update what we thought we knew.”

That is science working correctly.

This Cell study does not prove that everything previously believed about ADHD or stimulant medication was wrong. It gives us evidence that an established explanation may have been incomplete.

Five or ten years from now, our understanding will probably be different again.

I hope it is.

The goal should never be to defend today’s psychiatric model forever. The goal should be to keep refining it as our ability to understand the brain improves.

For patients, that means treatment should not be built around dogma.

It should be evidence-based, individualized, curious, and adaptable.

And perhaps the most useful question is not simply, “What medication improves attention?”

It may be:

“What is preventing this particular brain, in this particular body, living this particular life, from functioning the way this person wants it to?”

That is a much more interesting place to begin.

References

Kay BP, Wheelock MD, Siegel JS, et al. Stimulant medications affect arousal and reward, not attention networks. Cell. 2025;188(26):7529-7546.e20. doi:10.1016/j.cell.2025.11.039.

Additional information and patient education should not replace individualized medical evaluation or treatment. Do not start, stop, or change a prescription medication based solely on information in this article.